NCT05560854

Brief Summary

The primary objective with this study is to investigate the feasibility and acceptability of ten weeks of internet delivered prolonged exposure delivered through a digital platform with therapist support. The secondary objective is to investigate preliminary effects of internet delivered prolonged exposure in terms of reducing symptoms of post-traumatic stress, depression and increase quality of life.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 23, 2022

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 29, 2022

Completed
19 days until next milestone

Study Start

First participant enrolled

October 18, 2022

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 9, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 9, 2023

Completed
Last Updated

December 7, 2023

Status Verified

December 1, 2023

Enrollment Period

11 months

First QC Date

September 23, 2022

Last Update Submit

December 6, 2023

Conditions

Keywords

Prolonged exposureInternet-deliveredPTSD

Outcome Measures

Primary Outcomes (8)

  • Number of imaginal exposures made by the participant during the treatment period

    Number of imaginal exposures made by the participant during the treatment

    Through the treatment period, up to 10 weeks

  • Number of in vivo exposures made by the participant during the treatment period

    Number of in vivo exposures made by the participant during the treatment period

    Through the treatment period, up to 10 weeks

  • The proportion of participants that conducts the weekly measures and further assessment points

    The proportion of participants that conducts the weekly measures and further assessment points

    Through study completion up to the 6 months follow up]

  • The proportion of participants that go through the entire treatment period

    The proportion of participants that go through the entire treatment period

    Completion of the treatment period, ten weeks

  • Adverse events related to the treatment

    Treatment acceptability

    Through study completion, up to the 6 months follow up

  • Number of drop-outs from treatment

    Treatment acceptability

    Completion of the treatment period, up to 10 weeks

  • Participants experience/satisfaction with treatment and assessment procedures through qualitative interviews

    Qualitative interviews

    Completion of the treatment period up to the 6-month follow up

  • Participants satisfaction with treatment, assessed by The Client Satisfaction Questionnaire (CSQ-8).

    The CSQ-8 yields a single score measuring a single dimension of overall satisfaction. An "overall score" is calculated by summing the score on each of the eight scale item. Scores range from 8 to 32, with higher values indicating higher satisfaction.

    Completion of the treatment period, up to 10 weeks

Secondary Outcomes (5)

  • Change in PTSD symptoms as assessed by the Clinician Administered PTSD Scale (CAPS-5)

    Baseline, 1 month and 6 months follow up

  • Change in PTSD symptoms as assessed by the PTSD Check List - DSM-5 (PCL-5)

    Baseline, weekly through 10 weeks of treatment, post-treatment (immediately after treatment completion at 10 weeks), and the 1 month and 6 months follow up.

  • Change in ICD-11 PTSD and complex PTSD symptoms as assessed by the International Trauma Questionnaire (ITQ).

    Baseline, weekly through 10 weeks of treatment, post-treatment (immediately after treatment completion at 10 weeks), and the 1 month and 6 months follow up.

  • Change in depressive symptoms as measured by the Patient Health Questionnaire-9 (PHQ-9)

    Baseline, post-treatment (immediately after treatment completion at 10 weeks), and the 1 month and 6 months follow up.

  • Change in quality of life measured by Euroqol, EQ-5D

    Baseline, post-treatment (immediately after treatment completion at 10 weeks), and the 1 month and 6 months follow up.

Study Arms (1)

Internet delivered prolonged exposure

EXPERIMENTAL

Internet delivered prolonged exposure for ten weeks with therapist support.

Behavioral: Internet delivered prolonged exposure

Interventions

Internet delivered prolonged exposure for ten weeks with therapist support.

Internet delivered prolonged exposure

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Currently primary diagnosis PTSD according to DSM-5 diagnostic criteria for PTSD
  • ≥ 18 years
  • Fluent in Swedish
  • Signed informed consent

You may not qualify if:

  • PTSD is not the primary concern
  • Initiation or adjustment of any psychotropic medication within the last 4 weeks prior to commencement of treatment
  • Ongoing substance dependence
  • Current suicide risk meriting crisis intervention
  • Psychotic disorder
  • Ongoing trauma-focused psychological treatment
  • Ongoing trauma-related threat (e.g. living with a violent spouse)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Traumaprogrammet, Psykiatri Sydväst

Stockholm, Sweden

Location

Related Publications (1)

  • Bragesjo M, Ivanov VZ, Andersson E, Ruck C. Exploring the feasibility and acceptance of huddinge online prolonged exposure therapy (HOPE) for severe and complex PTSD. Eur J Psychotraumatol. 2024;15(1):2320607. doi: 10.1080/20008066.2024.2320607. Epub 2024 Mar 4.

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Study Officials

  • Maria Bragesjö, PhD

    Karolinska Institutet

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Prolonged exposure will be offered in a digital format with therapist support for ten weeks. Treatment comprises of psychoeducation, rationales, in vivo exposure, imaginal exposure, problems that can arise during exposure, hot spots and relapse prevention.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

September 23, 2022

First Posted

September 29, 2022

Study Start

October 18, 2022

Primary Completion

September 9, 2023

Study Completion

September 9, 2023

Last Updated

December 7, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations